Abstract
We investigated whether a peroxisome proliferator–activated receptor (PPAR) agonist would effect the angiotensin II (Ang II)–induced senescence of endothelial progenitor cells (EPCs). EPCs were isolated from peripheral blood and characterized. Both reverse transcription–polymerase chain reaction (RT-PCR) and Western blotting were used to assess gp91phox expression and angiotensin type 1 receptor (AT1R) levels. Immunofluorescence of nitrotyrosine provided evidence of peroxynitrite formation. Our data indicate that Ang II increased the expression of gp91phox mRNA, which was significantly diminished by pioglitazone, a PPARγ agonist. Western blotting revealed that Ang II stimulated an increase in the gp91phox protein, whereas co-treatment with pioglitazone significantly reduced this increase. In addition, pioglitazone also inhibited Ang II–induced peroxynitrite formation. Interestingly, pioglitazone decreased the expressions of AT1R mRNA and protein. The exposure of cultured EPCs to Ang II (100 nmol/L) significantly accelerated the rate of senescence compared to that of the control cells during 14 d in culture, as determined by acidic β-galactosidase staining. Ang II–induced EPC senescence was significantly inhibited by co-treatment with pioglitazone. Because cellular senescence is critically influenced by telomerase, which elongates telomeres, we also measured telomerase activity by means of PCR-ELISA–based assay. The results showed that Ang II significantly diminished telomerase activity, and this effect was significantly abolished by co-treatment with pioglitazone. In conclusion, pioglitazone inhibited Ang II–induced senescence of EPCs via down-regulation of the expression of AT1R
Similar content being viewed by others
Article PDF
References
Sorescu D, Weiss D, Lassegue B, et al: Superoxide production and expression of NOX family proteins in human atherosclerosis. Circulation 2002; 105: 1429–1435.
Azumi H, Inoue N, Takeshita S, et al: Expression of NADH/NADPH oxidase p22(phox) in human coronary arteries. Circulation 1999; 100: 1494–1498.
Zalba G, Beaumont FJ, San Jose G, et al: Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 2000; 35: 1055–1061.
Zhang H, Schmeisser A, Garlichs CD, et al: Angiotensin II–induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidase. Cardiovasc Res 1999; 44: 215–222.
Wattanapitayakul SK, Weinstein DM, Holycross BJ, Bauer JA : Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorder. FASEB J 2000; 14: 271–278.
Sohn HY, Raff U, Hoffmann A, et al: Differential role of angiotensin II receptor subtypes on endothelial superoxide formation. Br J Pharmacol 2000; 131: 667–672.
Chabrashvili T, Kitiyakara C, Blau J, et al: Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Integr Comp Physiol 2003; 285: R117–R124.
Imanishi T, Hano T, Nishio I : Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens 2005; 23: 97–104.
Bishop-Bailey D : Peroxisome proliferator–activated receptors in the cardiovascular system. Br J Pharmacol 2000; 129: 823–834.
Caballero AE, Saouaf R, Lim SC, et al: The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 3 diabetes: a placebo-controlled randomized clinical trial. Metabolism 2003; 52: 173–180.
Imanishi T, Hano T, Matsuo Y, Nishio I : Oxidized LDL inhibits vascular endothelial growth factor–induced endothelial progenitor cell differentiation. Clin Exp Pharmacol Physiol 2003; 30: 665–670.
Imanishi T, Hano T, Nishio I : Angiotensin II potentiates vascular endothelial growth factor–induced proliferation, and network formation in endothelial progenitor cells. Hypertens Res 2004; 27: 101–108.
Imanishi T, Kobayashi K, Kuki S, Takahashi C, Akasaka T : Sirolimus accelerates senescence of endothelial progenitor cells through telomerase inactivation. Atherosclerosis 2006; 189: 288–296.
Hill JM, Zalos G, Halcox JPJ, et al: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593–600.
Imanishi T, McBride J, Ho Q, O'Brien KD, Schwartz SM, Han DK : Expression of cellular FLICE-inhibitory protein in human coronary arteries and in a rat vascular injury model. Am J Pathol 2000; 156: 125–137.
Thum T, Fraccarollo D, Thum S, et al: Differential effects of organic nitrates on endothelial progenitor cells are determined by oxidative stress. Arterioslcer Thromb Vasc Biol 2007; 27: 748–754.
Dimri GP, Lee X, Basile G, et al: A biomarker that identifies senescent human cells in culture and in aging skin in vitro. Proc Natl Acad Sci U S A 1995; 92: 9363–9367.
Imanishi T, Hano T, Nishio I : Estrogen reduces angiotensin II–induced acceleration of senescence in endothelial progenitor cells. Hypertens Res 2005; 28: 263–271.
Vasa M, Fichtlscherer S, Aicher A, et al: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: e1–e7.
Min TQ, Zhu CJ, Xiang WX, Hui ZJ, Peng SY : Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc Drugs Therapy 2004; 18: 203–209.
Bodnar AG, Ouellette M, Frolkis M, et al: Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279: 349–352.
Counter CM, Hahn WC, Wei W, et al: Dissociation among in vitro telomerase activity, telomere maintenance, and cellular senescence. Proc Natl Acad Sci U S A 1998; 95: 14723–14728.
Yang J, Chang E, Cherry AM, et al: Human endothelial cell life extension by telomerase expression. J Biol Chem 1999; 274: 26141–26148.
Murasawa S, Llevadot J, Silver M, Isner JM, Losordo DW, Asahara T : Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 2002; 106: 1133–1139.
Edelberg JM, Tang L, Hattori K, Leiden D, Rafii S : Young adult bone marrow–derived endothelial progenitor cells restore aging-impaired cardiac angiogenic function. Circ Res 2002; 90: e89–e93.
Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C : Impaired progenitor activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005; 45: 1441–1448.
Cai H, Harrison DG : Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87: 840–844.
Vinten-Johansen J, Zhao ZQ, Nakamura M, et al: Nitric oxide and the vascular endothelium in myocardial ischemia-reperfusion injury. Ann N Y Acad Sci 1999; 874: 354–370.
Asahara T, Murohara T, Sullivan M, et al: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964–967.
Redonso S, Hristov M, Gumbel D, Tejerina T, Weber C : Biphasic effect of pioglitazone on isolation human endothelial progenitor cells: involvement of peroxisome proliferator–activated receptor-gamma and transforming factor-beta-1. Thromb Haemost 2007; 97: 979–987.
Sorrentino SA, Bahlmann FH, Besler C, et al: Oxidant stress impairs in vivo reendotheliazation capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus. Restoration by the peroxisome proliferator–activated receptor-γ agonist rosiglitazone. Circulation 2007; 116: 163–173.
Rafii S, Heissig B, Hattori K : Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors. Gene Ther 2002; 9: 631–641.
Flamme I, Brier G, Risau W : Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and differentiation in the quail embryo. Dev Biol 1995; 169: 699–712.
Vittet D, Prandini MH, Berthier R, et al: Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood 1996; 88: 3424–3431.
Dong C, Crawford L, Goldschmidt-Clermont PJ : Endothelial progenitor obsolescence and atheosclerotic inflammation. J Am Coll Cardiol 2005; 45: 1458–1460.
Werner N, Kosiol S, Schiegl T, et al: Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999–1007.
Hur J, Yang HM, Yoon CH, et al: Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies. Circulation 2007; 116: 1671–1682.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Imanishi, T., Kobayashi, K., Kuroi, A. et al. Pioglitazone Inhibits Angiotensin II–Induced Senescence of Endothelial Progenitor Cell. Hypertens Res 31, 757–765 (2008). https://doi.org/10.1291/hypres.31.757
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.757
Keywords
This article is cited by
-
Chronic Intermittent Hypoxia Triggers a Senescence-like Phenotype in Human White Preadipocytes
Scientific Reports (2020)
-
STAT1 mediates cellular senescence induced by angiotensin II and H2O2 in human glomerular mesangial cells
Molecular and Cellular Biochemistry (2012)